Last update 08 May 2025

NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)

Overview

Basic Info

Drug Type
DNA vaccine, Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Immune System DiseasesInfectious DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
HIV Infections
Originator Organization
National Institute of Allergy & Infectious Diseases
Active Organization-
Inactive Organization
National Institute of Allergy & Infectious Diseases
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)
NCT01927835
/ WithdrawnPhase 1IIT
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Homologous and Heterologous Prime-Boost Regimens Comprising DNA-HIV-PT123, NYVAC-HIV-PT1 and NYVAC-HIV-PT4, and AIDSVAX B/E in Healthy, HIV-Uninfected US and South African Adults
NCT01783977
/ CompletedPhase 1IIT
A Phase 1 Clinical Trial to Evaluate Safety and to Compare the Immunogenicity of 3 DNA Vaccine Prime Schedules Followed by a NYVAC Vaccine Boost in Healthy, HIV-1 Uninfected Adult Participants
100 Clinical Results associated with NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Translational Medicine associated with NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Patents (Medical) associated with NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)
Login to view more data
100 Deals associated with NYVAC-HIV-PT4(National Institute of Allergy & Infectious Diseases)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 1
Switzerland
National Institute of Allergy & Infectious Diseases
01 Apr 2013
HIV InfectionsPhase 1
United States
National Institute of Allergy & Infectious Diseases
01 Apr 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free